Roivant Sciences Ltd (ROIV)

Gross profit margin

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Gross profit (ttm)	US$ in thousands	69,701	86,854	111,567	142,979	109,235	102,707	77,963	53,020	38,203	28,977	43,206	41,920	46,320	52,224	34,333	27,335	21,738	7,070
Revenue (ttm)	US$ in thousands	76,195	97,555	125,677	158,303	124,795	123,241	103,153	78,585	61,280	43,127	50,416	51,870	55,286	61,209	42,618	29,954	23,795	8,649
Gross profit margin		91.48%	89.03%	88.77%	90.32%	87.53%	83.34%	75.58%	67.47%	62.34%	67.19%	85.70%	80.82%	83.78%	85.32%	80.56%	91.26%	91.36%	81.74%

March 31, 2025 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $69,701K ÷ $76,195K
= 91.48%

Roivant Sciences Ltd's gross profit margin has shown fluctuations over the period from December 31, 2020, to March 31, 2025. The company started with a strong gross profit margin of 81.74% in December 2020, which increased significantly to 91.36% by March 2021. This upward trend continued, reaching a peak of 91.48% by March 2025.

However, there were periods of decline and volatility in the gross profit margin during this timeframe. For instance, there was a notable decrease in September 2022 to 80.56% followed by a further decline to 67.19% by December 2022. This significant drop could raise concerns about the company's cost management or pricing strategies.

Following the decrease, there was a gradual recovery in the gross profit margin, reaching 91.48% by March 2025. It is essential for Roivant Sciences Ltd to monitor its gross profit margin closely to ensure sustainable profitability and efficient cost control measures.